These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3266994)

  • 21. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.
    Hørslev-Petersen K; Saxne T; Haar D; Thomsen BS; Bentsen KD; Junker P; Lorenzen I
    Rheumatol Int; 1988; 8(1):1-9. PubMed ID: 3259005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cartilage derived proteoglycans in body fluids of children. Inverse correlation with age.
    Saxne T; Castro F; Rydholm U; Svantesson H
    J Rheumatol; 1989 Oct; 16(10):1341-4. PubMed ID: 2810259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentration of interleukin-1 beta in serum and synovial fluid in patients with rheumatoid arthritis and those with osteoarthritis.
    Mannami K; Mitsuhashi T; Takeshita H; Okada K; Kuzuhara A; Yamashita F; Sakakida K
    Nihon Seikeigeka Gakkai Zasshi; 1989 Nov; 63(11):1343-52. PubMed ID: 2614163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of human cartilage proteoglycan synthesis by rheumatoid synovial fluid mononuclear cells activated with mycobacterial 60-kd heat-shock protein.
    Wilbrink B; Holewijn M; Bijlsma JW; van Roy JL; den Otter W; van Eden W
    Arthritis Rheum; 1993 Apr; 36(4):514-8. PubMed ID: 8457226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human monocyte elastolytic activity, the propeptides of types I and III procollagen, proteoglycans, and interleukin-6 in synovial fluid from patients with arthritis.
    Jensen HS; Jensen LT; Saxne T; Diamant M; Bendtzen K
    Clin Exp Rheumatol; 1991; 9(4):391-4. PubMed ID: 1934688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of pathological synovial fluids on the metabolism of chondrocytes].
    Mitsui K
    Nihon Seikeigeka Gakkai Zasshi; 1987 Jun; 61(6):681-93. PubMed ID: 3681068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
    Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
    Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
    Lundberg C; Asberg I; Ionescu M; Reiner A; Smedegård G; Poole AR
    Ann Rheum Dis; 1996 Aug; 55(8):525-34. PubMed ID: 8774180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
    Saxne T; Wollheim FA; Pettersson H; Heinegård D
    Br Med J (Clin Res Ed); 1987 Dec; 295(6611):1447-8. PubMed ID: 3121058
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibody to interleukin 1 inhibits the cartilage degradative and thymocyte proliferative actions of rheumatoid synovial culture medium.
    Yodlowski ML; Hubbard JR; Kispert J; Keller K; Sledge CB; Steinberg JJ
    J Rheumatol; 1990 Dec; 17(12):1600-7. PubMed ID: 2084232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-16 in synovial fluids from cases of various types of arthritis.
    Kageyama Y; Ozeki T; Suzuki M; Ichikawa T; Miura T; Miyamoto S; Machida A; Nagano A
    Joint Bone Spine; 2000; 67(3):188-93. PubMed ID: 10875316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis.
    Ishiguro N; Ito T; Oguchi T; Kojima T; Iwata H; Ionescu M; Poole AR
    Arthritis Rheum; 2001 Nov; 44(11):2503-11. PubMed ID: 11710706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints.
    Endo H; Akahoshi T; Takagishi K; Kashiwazaki S; Matsushima K
    Lymphokine Cytokine Res; 1991 Aug; 10(4):245-52. PubMed ID: 1932367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis.
    Witter J; Roughley PJ; Webber C; Roberts N; Keystone E; Poole AR
    Arthritis Rheum; 1987 May; 30(5):519-29. PubMed ID: 2439090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1beta in plasma and synovial fluid in relation to radiographic changes in arthritic temporomandibular joints.
    Nordahl S; Alstergren P; Eliasson S; Kopp S
    Eur J Oral Sci; 1998 Feb; 106(1):559-63. PubMed ID: 9527355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method for the quantification of cartilage proteoglycan structures liberated to the synovial fluid during developing degenerative joint disease.
    Heinegård D; Inerot S; Wieslander J; Lindblad G
    Scand J Clin Lab Invest; 1985 Sep; 45(5):421-7. PubMed ID: 4035279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid.
    Schalkwijk J; Joosten LA; van den Berg WB; van Wyk JJ; van de Putte LB
    Arthritis Rheum; 1989 Jan; 32(1):66-71. PubMed ID: 2912464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.